NCT01686321View on ClinicalTrials.gov

Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 4, 2012

Primary Completion Date

August 8, 2018

Study Completion Date

August 8, 2018

Conditions

Aggressive Lymphoma

Interventions

DRUG

Bendamustine and subcutaneous rituximab

Trial Locations (1)

37075

Prof. Trümper, Göttingen

All Listed Sponsors

collaborator

Roche Pharma AG

INDUSTRY

collaborator

Mundipharma Research GmbH & Co KG

INDUSTRY

lead

University of Göttingen

OTHER

NCT01686321 - Rituximab and Bendamustine in Very Elderly Patients or Elderly Medically Non Fit Patients With Aggressive B-cell Lymphoma | Biotech Hunter | Biotech Hunter